A randomized phase II trial of three novel regimens for relapsed/refractory acute myeloid leukemia (AML) demonstrates encouraging results with a flavopiridol-based regimen: Results of Eastern Cooperative Oncology Group (ECOG) trial E1906 Meeting Abstract
| Authors: | Litzow, M. R.; Wang, X. V.; Carroll, M. P.; Karp, J. E.; Ketterling, R.; Kaufmann, S. H.; Lazarus, H. M.; Luger, S. M.; Paietta, E. M.; Rowe, J. M.; Altman, J. K.; Pratz, K. W.; Broun, E. R.; Tallman, M. S. |
| Abstract Title: | A randomized phase II trial of three novel regimens for relapsed/refractory acute myeloid leukemia (AML) demonstrates encouraging results with a flavopiridol-based regimen: Results of Eastern Cooperative Oncology Group (ECOG) trial E1906 |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243505025 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.3742.3742 |
| Notes: | Meeting Abstract: 3742 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
